AM ET, and the only question that matters is whether Carvykti's growth is still outpacing J&J's Tecvayli with anito-cel's ...

UC Santa Cruz deepens industry engagement to underscore its vital role in contributing basic research and tomorrow’s talent, convening its first international RNA biotech conference on August 18 ...

Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, ...

Michelle Ross, Stempoint Capital CIO, joins 'Closing Bell' to talk her perspective on the Biotech sector, companies she is ...

Scientists at the Department of Energy's Oak Ridge National Laboratory have created a platform that pinpoints genetic ...

The CBO CEO relationship shapes biotech deal success. Discover insights from 19 industry leaders on board alignment and partnering.

Generate Biomedicines focuses on AI-enabled drug discovery.

The startup is the 12th drug company to bank at least $250 million in an IPO this year, nearly matching totals last seen ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Georgia Witchel's Mantis Biotech makes Parva, consumer software that reads how a person types and clicks to flag cognitive ...